Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43.4M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
17.4M
-
Shares change
-
+5.95M
-
Total reported value, excl. options
-
$11.9M
-
Value change
-
+$3.98M
-
Number of buys
-
18
-
Number of sells
-
-20
-
Price
-
$0.68
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q2 2025
58 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q2 2025.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.4M shares
of 43.4M outstanding shares and own 39.97% of the company stock.
Largest 10 shareholders include Bleichroeder LP (6.82M shares), GC Wealth Management RIA, LLC (3.33M shares), VANGUARD GROUP INC (3.19M shares), GEODE CAPITAL MANAGEMENT, LLC (692K shares), Robertson Stephens Wealth Management, LLC (479K shares), BlackRock, Inc. (449K shares), BANK OF AMERICA CORP /DE/ (325K shares), UBS Group AG (293K shares), ADVISORY RESEARCH INC (257K shares), and STIFEL FINANCIAL CORP (197K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.